ARCHIVES

ACS Prostate Cancer Recommendations Move Forward

This article is from The Cancer Letter archive.

Vol. 18 No. 32 | August 7, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

September 30, 2005

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983